Proton Pump Inhibitors (PPIs) Market (Drug Type: Omeprazole, Pantoprazole, Esomeprazole, Lansoprazole, Rabeprazole, and Others; and Indication Type: Gastroesophageal Reflux Disease and Peptic Ulcers) - Global Industry Analysis, Size, Share, Growth, Trends

Proton Pump Inhibitors (PPIs) Market (Drug Type: Omeprazole, Pantoprazole, Esomeprazole, Lansoprazole, Rabeprazole, and Others; and Indication Type: Gastroesophageal Reflux Disease and Peptic Ulcers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Proton Pump Inhibitors (PPIs) Market – Scope of Report

TMR’s report on the global proton pump inhibitors (PPIs) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global proton pump inhibitors (PPIs) market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global proton pump inhibitors (PPIs) market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the proton pump inhibitors (PPIs) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global proton pump inhibitors (PPIs) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global proton pump inhibitors (PPIs) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global proton pump inhibitors (PPIs) market.

The report delves into the competitive landscape of the global proton pump inhibitors (PPIs) market. Key players operating in the global proton pump inhibitors (PPIs) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global proton pump inhibitors (PPIs) market profiled in this report.

Key Questions Answered in Global proton pump inhibitors (PPIs) Market Report
  • What is the sales/revenue generated by proton pump inhibitors (PPIs) across all regions during the forecast period?
  • What are the opportunities in the global proton pump inhibitors (PPIs) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Proton Pump Inhibitors (PPIs) Market – Research Objectives and Research Approach

The comprehensive report on the global proton pump inhibitors (PPIs) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global proton pump inhibitors (PPIs) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global proton pump inhibitors (PPIs) market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Proton Pump Inhibitors (PPIs) Market
4. Market Overview
  4.1. Introduction
4.1.1. Segment Definition
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, 2020-2034
  4.5. Porter’s Five Force Analysis
5. Key Insights
  5.1. Regulatory Scenario
  5.2. Product Approval/Launches
  5.3. Pipeline Analysis
6. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Drug Type
  6.1. Introduction & Definition
  6.2. Key Findings / Developments
  6.3. Market Value Forecast By Drug Type, 2020-2034
6.3.1. Omeprazole
6.3.2. Pantoprazole
6.3.3. Esomeprazole
6.3.4. Lansoprazole
6.3.5. Rabeprazole
6.3.6. Others (Dexlansoprazole, etc.)
  6.4. Market Attractiveness By Drug Type
7. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Indication Type
  7.1. Introduction & Definition
  7.2. Key Findings / Developments
  7.3. Market Value Forecast By Indication Type, 2020-2034
7.3.1. Gastroesophageal Reflux Disease
7.3.2. Peptic Ulcers
  7.4. Market Attractiveness By Indication Type
8. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By End-user
  8.1. Introduction & Definition
  8.2. Key Findings / Developments
  8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
  8.4. Market Attractiveness By End-user
9. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Region
  9.1. Key Findings
  9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
  9.3. Market Attractiveness By Country/Region
10. North America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
  10.1. Introduction
10.1.1. Key Findings
  10.2. Market Value Forecast By Drug Type, 2020-2034
10.2.1. Omeprazole
10.2.2. Pantoprazole
10.2.3. Esomeprazole
10.2.4. Lansoprazole
10.2.5. Rabeprazole
10.2.6. Others (Dexlansoprazole, etc.)
  10.3. Market Value Forecast By Indication Type, 2020-2034
10.3.1. Gastroesophageal Reflux Disease
10.3.2. Peptic Ulcers
  10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
  10.5. Market Value Forecast By, 2020-2034
  10.6. Market Value Forecast By Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
  10.7. Market Attractiveness Analysis
10.7.1. By Drug Type
10.7.2. By Indication Type
10.7.3. By End-user
10.7.4. By Country
11. Europe Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
  11.1. Introduction
11.1.1. Key Findings
  11.2. Market Value Forecast By Drug Type, 2020-2034
11.2.1. Omeprazole
11.2.2. Pantoprazole
11.2.3. Esomeprazole
11.2.4. Lansoprazole
11.2.5. Rabeprazole
11.2.6. Others (Dexlansoprazole, etc.)
  11.3. Market Value Forecast By Indication Type, 2020-2034
11.3.1. Gastroesophageal Reflux Disease
11.3.2. Peptic Ulcers
  11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
  11.5. Market Value Forecast By, 2020-2034
  11.6. Market Value Forecast By Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
  11.7. Market Attractiveness Analysis
11.7.1. By Drug Type
11.7.2. By Indication Type
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
  12.1. Introduction
12.1.1. Key Findings
  12.2. Market Value Forecast By Drug Type, 2020-2034
12.2.1. Omeprazole
12.2.2. Pantoprazole
12.2.3. Esomeprazole
12.2.4. Lansoprazole
12.2.5. Rabeprazole
12.2.6. Others (Dexlansoprazole, etc.)
  12.3. Market Value Forecast By Indication Type, 2020-2034
12.3.1. Gastroesophageal Reflux Disease
12.3.2. Peptic Ulcers
  12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
  12.5. Market Value Forecast By, 2020-2034
  12.6. Market Value Forecast By Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. India
12.6.3. Japan
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
  12.7. Market Attractiveness Analysis
12.7.1. By Drug Type
12.7.2. By Indication Type
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
  13.1. Introduction
13.1.1. Key Findings
  13.2. Market Value Forecast By Drug Type, 2020-2034
13.2.1. Omeprazole
13.2.2. Pantoprazole
13.2.3. Esomeprazole
13.2.4. Lansoprazole
13.2.5. Rabeprazole
13.2.6. Others (Dexlansoprazole, etc.)
  13.3. Market Value Forecast By Indication Type, 2020-2034
13.3.1. Gastroesophageal Reflux Disease
13.3.2. Peptic Ulcers
  13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
  13.5. Market Value Forecast By, 2020-2034
  13.6. Market Value Forecast By Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
  13.7. Market Attractiveness Analysis
13.7.1. By Drug Type
13.7.2. By Indication Type
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
  14.1. Introduction
14.1.1. Key Findings
  14.2. Market Value Forecast By Drug Type, 2020-2034
14.2.1. Omeprazole
14.2.2. Pantoprazole
14.2.3. Esomeprazole
14.2.4. Lansoprazole
14.2.5. Rabeprazole
14.2.6. Others (Dexlansoprazole, etc.)
  14.3. Market Value Forecast By Indication Type, 2020-2034
14.3.1. Gastroesophageal Reflux Disease
14.3.2. Peptic Ulcers
  14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
  14.5. Market Value Forecast By, 2020-2034
  14.6. Market Value Forecast By Country, 2020-2034
14.6.1. GCC
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
  14.7. Market Attractiveness Analysis
14.7.1. By Drug Type
14.7.2. By Indication Type
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  15.2. Company Profiles
15.2.1. Pfizer
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Teva Pharmaceutical Industries Ltd.
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. LUPIN Limited
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. Amneal Pharmaceuticals LLC
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Zydus Cadila
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. Sun Pharmaceutical Industries Ltd.
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. Alembic Pharmaceuticals Limited
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments
15.2.8. Sanofi S.A.
15.2.8.1. Company Overview
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Business Strategies
15.2.8.5. Recent Developments
15.2.9. AstraZeneca
15.2.9.1. Company Overview
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Business Strategies
15.2.9.5. Recent Developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings